SSRINot Controlled Black Box Warning

Lexapro®

Escitalopram

Generic·FDA 2002·
5mg10mg20mg

Version 2025-04 · Last reviewed April 1, 2025 · Methodology

List Price

$120

With Insurance

$10-30

The Short Version

Plain-language summary

Lexapro (Escitalopram) boosts serotonin in the brain more precisely than most antidepressants. Its selectivity is why it tends to have fewer side effects while still effectively treating depression and anxiety.

How it works: Escitalopram is the most selective SSRI (a type of antidepressant) available. It blocks serotonin (a brain chemical that affects mood) reuptake via two binding sites on the SERT transporter, the primary active site plus a unique allosteric site, making it more effective at keeping the transporter blocked than other SSRIs at equivalent doses.

What people most commonly report

Nausea
15%
Sexual dysfunction
14-20%
Insomnia
14%
Diarrhea
12%
Dry mouth
9%

Take with food; improves significantly after 1-2 weeks

Check the evidence section for details on who funded the research.

What Else the Evidence Supports

Non-drug options with clinical backing

CBT and exercise match escitalopram effectiveness in multiple trials

CBTEmerging

Equal efficacy to SSRIs; lower relapse rate.

Mindfulness-Based Therapy (MBCT)Emerging

Reduces relapse in recurrent depression by 43%.

ExerciseEmerging

Equivalent to antidepressants in multiple RCTs.

MagnesiumEmerging

RCT: reduced depression scores significantly.

What This Really Costs

Long-term cost projection based on current pricing

Monthly

$35

$20 w/ insurance

without insurance

Annual

$420

$240 w/ insurance

without insurance

10 Years

$4.2K

$2.4K w/ insurance

without insurance

30 Years

$12.6K

$7.2K w/ insurance

without insurance

Lifestyle alternative: $0/month in prescriptions. CBT - Equal efficacy to SSRIs; lower relapse rate.

The average American retiree spends $165,000 on healthcare after retirement (Fidelity, 2024). Informed choices today compound over decades.

Related Evidence

Explore related medications reviewed on EvidentMeds

FDA Black Box Warning

INCREASED SUICIDAL THOUGHTS IN UNDER 25

Monitor closely in first months.

Strict Contraindications

MAOIs within 14 daysPimozide

Metabolic & Lifestyle Alternatives

Non-Pharmacological Anxiety & Depression Treatments

CBT and exercise match escitalopram effectiveness in multiple trials

Important context: Evidence quality varies across these approaches. Some are well-studied with randomized controlled trial data; others are based on observational or smaller studies. These interventions are not guaranteed to replace medication for all patients. Discuss with your doctor whether any of these are appropriate for your clinical situation.

Global Prescribing & Pricing

US SSRI prescribing rates are approximately 3–4× higher than comparable European countries per capita

🇺🇸

United States

$10–20 (generic)/mo

Rate

Top-10 prescribed drug; widely used for depression and anxiety

Policy

Any physician can prescribe; therapy not required before or during treatment

Cover

Varies by plan

🇬🇧

United Kingdom

~$1–4/mo

Rate

Lower prescribing, therapy-first model per NICE

Policy

CBT or talking therapy required before SSRIs for mild-to-moderate cases; free IAPT access

Cover

Fully covered by NHS

🇩🇪

Germany

~$9–22/mo

Rate

~6% of adults, psychotherapy co-subsidized

Policy

GKV pays for psychotherapy alongside medication; integrated treatment model is standard

Cover

Covered by GKV

🇸🇪

Sweden

~$3–10/mo

Rate

~6% of adults, stepped care with exercise option

Policy

Structured exercise programs prescribable; stepped care ensures non-drug options first

Cover

Covered by Landsting

🇯🇵

Japan

~$10–27/mo

Rate

Lower prescribing, cultural stigma + psychiatrist gatekeeping

Policy

Psychiatrist referral often required; shorter-duration prescriptions standard; strong social stigma

Cover

Covered by JHIS

Germany's GKV health insurance subsidizes psychotherapy wait times, meaning most patients access CBT before or alongside medication. A 2022 Lancet study confirmed medication + therapy produces better long-term outcomes than medication alone, yet only Germany and the UK make that the default path.

Clinical Trials & Funding

Understanding who funds research helps contextualize results. Industry-funded trials are not automatically invalid - they undergo the same FDA review - but declared conflicts and sponsor effects are worth knowing. All linked trials can be verified on ClinicalTrials.gov.

Key Efficacy Results

Response 50-60%, remission 35%; slightly better tolerated than most SSRIs

Referenced Studies

Each study shows its evidence level and Cochrane RoB-2 risk-of-bias rating - tap the bias badge for details.

Evidence & Transparency

Cochrane RoB-2 (Risk of Bias)

Badges reflect an editorial assessment using Cochrane's RoB-2 tool domains: randomization, intervention deviation, missing data, outcome measurement, and selective reporting. These are not certified Cochrane reviews. Learn more ↗

CMS Open Payments

Manufacturer payment disclosures are reported via the CMS Sunshine Act. Disclosure is legally required and does not imply bias or misconduct. Language uses "may," "suggests," or "appears", never definitive clinical claims. CMS Open Payments ↗

Live Clinical Trials

Live from ClinicalTrials.gov · refreshed every 4 hours

Currently enrolling, active, and recently completed studies involving Escitalopram. Data is pulled directly from the U.S. National Library of Medicine.

Recent Research

Live from PubMed · peer-reviewed literature · refreshed every 4 hours

Most recently indexed clinical trials and systematic reviews mentioning Escitalopram in PubMed.

Source Documentation

Structured citations for referenced clinical trials

Each referenced trial is listed with its registry ID, funding source, and bias assessment. Use the copy button to generate a formatted citation.

TrialRegistry IDCite
Escitalopram MDD (Forest)NCT00668525

Bias ratings use Cochrane RoB-2 methodology. Editorial assessment - not a certified Cochrane review.

Our Methodology

Common Side Effects

While taking this medication, you may experience the following common side effects. We've included tips on how to manage them.

Nausea

15%

Take with food; improves significantly after 1-2 weeks

Sexual dysfunction

14-20%

Talk to your doctor; options include dose adjustment or adding another medication

Insomnia

14%

Take in the morning; sleep hygiene practices help

Diarrhea

12%

Usually improves with time; take with food

Dry mouth

9%

Sip water frequently; sugar-free gum helps

Headache

8%

Common at start; usually resolves within weeks

Fatigue / drowsiness

8%

May improve; consider taking at night

Sweating

7%

Often worse at night; usually improves with time

Weight gain

5-10% long-term

Monitor weight; regular exercise helps mitigate

Tremor

5%

Report if bothersome; dose adjustment may help

Serious Adverse Effects

  • Suicidal ideation (under-25, first weeks)
  • Serotonin syndrome
  • QT prolongation / cardiac arrhythmia
  • Discontinuation syndrome
  • Hyponatremia

Drug Interactions

Major Interactions (Avoid)

MAOIsPotentially fatal serotonin syndrome, contraindicated
PimozideQT prolongation, cardiac risk

Moderate Interactions (Caution)

CimetidineIncreases escitalopram levels 70%
NSAIDsGI bleeding risk increased

Food Interactions

AlcoholWorsens depression; increases sedation
St. John's WortSerotonin syndrome risk

When to Contact Your Doctor

This medication requires ongoing medical supervision. The following situations warrant a prompt conversation with your prescribing physician - do not wait for your next scheduled appointment.

Contact soon if you notice

  • Suicidal ideation (under-25, first weeks)
  • Serotonin syndrome
  • QT prolongation / cardiac arrhythmia
  • Discontinuation syndrome
  • "Brain zaps", electric shock sensations in the head

Also discuss if you want to

  • Review whether this medication is still appropriate for you
  • Consider dosage adjustments based on response
  • Explore lifestyle or non-drug alternatives
  • Understand stopping or tapering options
  • Plan monitoring labs and follow-up

In the US, call 911 or go to the nearest emergency room for severe symptoms. Poison Control: 1-800-222-1222.

Special Populations

Safety classifications for specific groups - discuss with your provider before use.

Use With CautionPregnancy

PPHN risk; weigh against depression risks.

Generally CompatibleBreastfeeding

Low milk levels; discuss with provider.

Frequently Overprescribed for Hormonal SymptomsMenopause / Hormonal

Depression, anxiety, and mood instability during perimenopause are often hormone-driven, not a primary psychiatric condition. Lexapro is widely prescribed for what is actually estrogen and progesterone fluctuation. Hormone therapy may be more effective and more directly addresses the cause. Ask about a hormonal workup before starting an SSRI for symptoms that began near menopause.

Approved 12+ for MDDChildren & Teens

FDA approved for adolescents. Black box warning.

Start Low 5mgOlder Adults

Hyponatremia risk; start at 5mg; max 10mg in elderly.

FDA Adverse Event Reports

Patient-filed reports from the FDA FAERS database · refreshed daily

Anecdotal data. Reports are not confirmed causation. Always consult your provider.

Community Reports

User-reported experiences - anonymous & anecdotal

Join the Conversation

Premium subscribers can share their experience and confirm others' reports.

Cancel anytime.

Stopping This Medication Safely

CRITICAL, Taper Very SlowlyDocumented timeframe: 8 weeks minimum; 4–6 months for long-term users

Escitalopram has among the highest rates of SSRI discontinuation syndrome due to its short half-life. Symptoms begin within 24–48 hours of stopping and can be severely disabling.

What Published Research Shows About Stopping This Medication

This summarizes what published research documents, it is not personal medical advice. Any changes to your medication require discussion with your prescribing physician.

  • ·Research shows discontinuation symptoms can begin within 24 hours of a missed dose, abrupt stopping is not documented as safe
  • ·Published tapering approaches describe reducing by 2.5–5mg every 4–6 weeks minimum
  • ·Liquid formulation is used by some patients for micro-tapering, this approach is supported by emerging evidence in sensitive individuals
  • ·Research supports having CBT or therapy established before beginning dose reduction
  • ·Clinical guidance suggests planning dose reduction during a lower-stress life period

Warning Symptoms, Contact Your Doctor If You Experience:

  • "Brain zaps", electric shock sensations in the head
  • Extreme dizziness and nausea
  • Severe mood swings
  • Insomnia and vivid nightmares
  • Anxiety worse than original symptoms
  • Flu-like body aches and sweating

Never change or stop a medication without consulting your prescribing physician.

Questions for Your Doctor

$2.99, printable guide for your next appointment

Questions to Ask

  • 1.Has the child's diet been evaluated? High-sugar and processed foods cause a blood sugar spike, then an insulin overcorrection, then a crash, and the body releases adrenaline to fix the crash. That adrenaline causes shakiness, anxiety, difficulty focusing, and restlessness, all of which can look exactly like ADHD. Has a dietary trial been done first?
  • 2.Should we try therapy alongside this?
  • 3.What side effects should I watch for?
  • 4.How long until I notice a difference?
  • 5.What is the plan for stopping if needed?

Lab Tests to Request

  • ECG (QT interval, especially if cardiac history)
  • Sodium (Na+)
  • Thyroid function
  • Vitamin D
  • Fasting blood sugar, to check for reactive hypoglycemia

Medical Disclaimer

The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.

Get notified when we update Lexapro®

We'll email you when new evidence, safety updates, or alternatives are added.

No spam. Unsubscribe anytime.

Found this useful?

Help keep EvidentMeds editorially independent and community supported. Every dollar funds transparent medication data.

Support the Mission